Adverum develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein.
https://www.google.com/url?rct=j&sa=t&url=https://www.marketbeat.com/instant-alerts/nasdaq-advm-a-buy-or-sell-right-now-2022-01/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNHL8iKexC9ucn3ql3CKpnYvwhXNEA
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.